SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-001264
Filing Date
2021-08-11
Accepted
2021-08-11 16:06:46
Documents
71
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q cere-20210630.htm   iXBRL 10-Q 2680316
2 EX-31.1 cere-20210630ex31_1.htm EX-31.1 15268
3 EX-31.2 cere-20210630ex31_2.htm EX-31.2 15244
4 EX-32.1 cere-20210630ex32_1.htm EX-32.1 9016
5 EX-32.2 cere-20210630ex32_2.htm EX-32.2 9000
6 GRAPHIC img31183384_0.jpg GRAPHIC 91905
  Complete submission text file 0000950170-21-001264.txt   8792053

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cere-20210630.xsd EX-101.SCH 53379
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cere-20210630_def.xml EX-101.DEF 194094
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cere-20210630_lab.xml EX-101.LAB 414098
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cere-20210630_cal.xml EX-101.CAL 42169
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cere-20210630_pre.xml EX-101.PRE 321022
12 EXTRACTED XBRL INSTANCE DOCUMENT cere-20210630_htm.xml XML 1540664
Mailing Address 222 JACOBS STREET SUITE 200 CAMBRIDGE MA 02141
Business Address 222 JACOBS STREET SUITE 200 CAMBRIDGE MA 02141 844-304-2048
Cerevel Therapeutics Holdings, Inc. (Filer) CIK: 0001805387 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39311 | Film No.: 211163453
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences